Alle Storys
Folgen
Keine Story von Korian Deutschland AG mehr verpassen.

Korian Deutschland AG

EANS-Adhoc: CURANUM AG
Publishing the results of Q3/ 2009

  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
quarterly report
12.11.2009
Ad hoc announcement
EUR 7.5 million of EBITDA in the third quarter of 2009
CURANUM AG, Munich, raised consolidated revenue from EUR 65.0 million
in the third quarter of 2008 to EUR 65.7 million in the third quarter
of 2009. This mainly reflects the first-time consolidation of our 
facility in Braunschweig and of our Seniorenresidenz Scheffelhof in 
Bad Dürrheim. In the first nine months of the current financial year,
we generated revenue of EUR 193.1 million compared with EUR 192.5 
million in the prior-year period.
In the third quarter of 2009, the personnel expense increased from 
EUR 32.2 million in the third quarter of 2008 by EUR 0.5 million or 
1.6% to EUR 32.7 million. This increase was due, firstly, to higher 
expenses for temporary labor, and, secondly, to the fact that one-off
Group restructuring expenses had an impact on the personnel expense. 
Rental expenses rose slightly from EUR 13.7 million in the third 
quarter of 2008 to EUR 13.8 million in the third quarter of 2009.
Compared with EBITDA generated in the first half-year quarters (Q1: 
EUR 6.4 million; Q2: EUR 6.2 million), EBITDA in the third quarter 
2009 was highly positive at EUR 7.5 million. Due to higher personnel,
rental and maintenance expenses, however, the figure was somewhat 
lower than in the third quarter of 2008 (EUR 7.9 million).
Earnings before interest and tax (EBIT) fell from EUR 5.5 million in 
the third quarter of 2008 to EUR 5.0 million in the third quarter of 
2009. In a year-on- year comparison, the EBIT margin declined from 
8.5% to 7.7% in the third quarter of 2009. Earnings after tax 
amounted to EUR 2.0 million in the third quarter of the current 
reporting period (previous year: EUR 2.4 million), while earnings per
share (EPS) totaled EUR 0.06 in the third quarter of 2009 (previous 
year: EUR 0.07 per share).
In the first nine months, EBITDA declined from EUR 22.6 million in 
the comparable period of the previous year to EUR 20.1 million. 
Earnings before interest and tax (EBIT) fell from EUR 15.5 million in
the first nine months of 2008 to EUR 12.8 million in 2009, earnings 
after tax amounted to EUR 4.2 million (previous year: EUR 6.2 
million), and earnings per share totaled EUR 0.13 (previous year: EUR
0.19).
During the first nine months of the current financial year, cash flow
from operating activities of EUR 14.1 million remained highly 
positive (previous year: EUR 15.4 million). Besides the lower pre-tax
result, this mainly reflected a reduction in interest payments and 
similar expenses, which were down from EUR 8.0 million to EUR 6.8 
million, and a change in working capital from minus EUR 3.7 million 
to minus EUR 4.6 million.
Shareholders' equity rose from EUR 64.1 million as of December 31, 
2008 to EUR 64.3 million as of September 30, 2009. Accordingly, the 
equity ratio amounted to 27.2% (December 31, 2008: 27.0%).
With regard to the upcoming months, we assume that the difficult 
competitive environment will continue, and we are not expecting 
improvements to set in until next year at the earliest. The 
utilization rate is expected to prospectively remain at the same 
level or to dip slightly due to the seasonally weaker demand in the 
fourth quarter. We are retaining our 2009 budget that has been in 
place to date. As far as earnings trends are concerned, however, we 
are assuming that the outcome will be at the lower end of the range 
that we have provided to date.
In the medium term, we are anticipating a recovery in the very low 
utilization rate of around 85% across Germany, since investments in 
care properties have declined sharply over the last 18 months, and 
the refinancing of new care facilities has become significantly more 
difficult in some Federal States (Bundesländer) due to the care home 
act legislation. For the 2010 financial year, however, we continue to
anticipate a highly competitive environment, and we are budgeting 
conservatively with revenue of between EUR 264.5 million and EUR 
266.5 million, EBITDA of between EUR 28.5 million and EUR 30.0 
million, and earnings after tax between EUR 6.5 million and EUR 7.5 
million. These forecasts do not take any acquisitions into account.
Munich, November 12, 2009
The Management Board
|Key figures IFRS as of September 30, 2009 |         |         |         |
|                         |        |        |         |         |         |
|mil. Euro                |Q 3 2009|Q 3 2008|9M-2009  |9M-2008  |2008     |
|                         |        |        |         |         |         |
|Sales                    |65.7    |65.0    |193.1    |192.5    |257.1    |
|Staff costs              |32.7    |32.2    |97.5     |96.0     |127.8    |
|EBITDAR                  |21.4    |21.6    |61.8     |63.5     |83.9     |
|Rental costs             |13.8    |13.7    |41.6     |40.9     |54.6     |
|EBITDA                   |7.5     |7.9     |20.1     |22.6     |29.3     |
|in % of Sales            |11.4%   |12.2%   |10.4%    |11.7%    |11.4%    |
|Depreciation             |2.5     |2.4     |7.3      |7.1      |9.5      |
|EBIT                     |5.0     |5.5     |12.8     |15.5     |19.7     |
|in % of Sales            |7.7%    |8.5%    |6.7%     |8.1%     |7.7%     |
|Financial results        |-2.3    |-2.3    |-6.7     |-7.1     |-9.5     |
|EBT                      |2.7     |3.1     |6.1      |8.4      |10.2     |
|Net profit               |2.0     |2.4     |4.2      |6.2      |7.0      |
|EPS (EUR)*               |0.06    |0.08    |0.13     |0.19     |0.22     |
|                         |        |        |         |         |         |
|Cashflow                 |5.4     |6.4     |14.1     |15.4     |19.8     |
|CPS (EUR) **             |0.17    |0.20    |0.44     |0.47     |0.61     |
|                         |        |        |         |         |         |
|Cash and cash equivalents|7.6     |9.1     |7.6      |9.1      |10.0     |
|Equity capital           |64.3    |65.2    |64.3     |65.2     |64.1     |
|in % of Balance sheet    |27.2%   |26.9%   |27.2%    |26.9%    |27.0%    |
|total                    |        |        |         |         |         |
|Balance sheet total      |236.8   |242.1   |236.8    |242.1    |237.7    |
|                         |        |        |         |         |         |
|Employees                |6,091   |5,978   |6,056    |5,964    |5,953    |
|Facilities               |69      |67      |69       |67       |68       |
|Care places              |7,805   |7,651   |7,805    |7,651    |7,708    |
|Assisted living          |1,681   |1,630   |1,681    |1,630    |1,638    |
|apartements              |        |        |         |         |         |
|                         |        |        |         |         |         |
|                         |        |        |         |         |         |
|                         |        |        |         |         |         |
|*) Number of underlying outstanding shares in                 |         |
|Q3/2009: 32,254,898 shares                                    |         |
|*) Number of underlying outstanding shares in                 |         |
|Q3/2008: 32,660,000 shares                                    |         |
|*) Number of underlying outstanding shares 9M/2009: 32,289,742|         |
|shares                                                        |         |
|*) Number of underlying outstanding shares 9M/2008: 32,660,000|         |
|shares                                                        |         |
|**) Cash Flow from operating activities: number of outstanding shares   |
end of announcement                               euro adhoc

Further inquiry note:

Bettina Pöschl
Tel. +49(0)89-242065-69
E-Mail: bettina.poeschl@curanum.de

Branche: Healthcare Providers
ISIN: DE0005240709
WKN: 524070
Index: SDAX, CDAX, Classic All Share, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / regulated dealing

Weitere Storys: Korian Deutschland AG
Weitere Storys: Korian Deutschland AG
  • 13.08.2009 – 08:35

    EANS-Adhoc: CURANUM AG / Figures Q2-2009/ HY1 2009

    ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 6-month report/Figures Q2-2009 / HY1 2009 13.08.2009 Ad hoc announcement Second-quarter revenue within budget CURANUM AG, Munich, achieved revenue of EUR 64.3 million in the second quarter of 2009. This represents an ...

  • 05.08.2009 – 15:59

    EANS-News: CURANUM AG / New CFO at CURANUM

    Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. companies/New CFO at CURANUM München (euro adhoc) - [pic] Press release New CFO at CURANUM The Supervisory Board of CURANUM AG, Munich, one of the largest private care facility operators in Germany, has appointed Judith Barth (38) as the company's new CFO with immediate ...